IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 1589 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
 
ORIGINAL ARTICLE
Ahead of Print

Psoriasis increases the risk of concurrent inflammatory bowel disease: A population-based nationwide study in Korea


1 Public Health Medical Service, SMG-SNU Boramae Medical Center, Seoul, Korea
2 Institute of Health and Environment, Seoul National University, Seoul, Korea
3 Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul, Korea
4 Department of Dermatology, Seoul National University Hospital, Seoul, Korea
5 Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul, Korea
6 Dermatology, SMG-SNU Boramae Medical Center, Seoul, Korea

Correspondence Address:
Hyun-Sun Park,
20 Boramae-Ro-5-Gil, Dongjak-Gu, Seoul 07061
Korea
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijdvl.IJDVL_875_17

PMID: 30058564

Background: The epidemiology of the association between psoriasis and inflammatory bowel disease is poorly defined and remains controversial. Aim: To evaluate the prevalence of inflammatory bowel disease in patients with psoriasis compared with the general population. Methods: We searched the nationwide health claims database between 2011 and 2015 and evaluated the prevalence of inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Results: Prevalence of inflammatory bowel disease, Crohn's disease and ulcerative colitis in patients with psoriasis vs the general population in 2011 were 0.16, 0.05 and 0.12% vs 0.08, 0.03 and 0.06%, respectively, which increased significantly with time between 2011 and 2015. Patients with psoriasis consistently revealed higher standardized prevalence (age and sex adjusted) of inflammatory bowel disease, Crohn's disease and ulcerative colitis compared with the general population. Subgroup analysis revealed the highest risk of prevalent inflammatory bowel disease in patients younger than 19 years (crude odds ratio 5.33, 95% confidence interval 3.74–7.59). Severe psoriasis demonstrated higher odds of inflammatory bowel disease (odds ratio 2.96, 95% confidence interval 2.54–3.45) than mild psoriasis (odds ratio 1.68, 95% confidence interval 1.51–1.88). Limitations: Limited data for doing adjustment and cross-sectional study design. Conclusions: Psoriasis patients revealed higher risk of inflammatory bowel disease. In particular, young patients and those with severe psoriasis may require closer monitoring and comprehensive management.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Lee JY
    -  Kang S
    -  Bae JM
    -  Jo SJ
    -  Koh SJ
    -  Park HS
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed218    
    PDF Downloaded23    

Recommend this journal

Online since 15th March '04
Published by Wolters Kluwer - Medknow